NCT06084585

The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia

A Three Arms, Randomized, Double-blind Controlled Trial of the Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 180 (estimated)
• Sponsor: Amway (China) R&D Center · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this three arms, randomized, double-blind controlled interventional study is to evaluate the efficacy of Amway uric acid lowering product improving hyperuricemia in patients aged 18 and 65 years old. The main question it aims to answer is: \- whether the serum uric acid level of patients with hyperuricemia could be significantly lowered after 3 months intervention with Amway uric acid lowering product 180 eligible participants will be enrolled in one study site and randomized to three study groups (two product group and one placebo group), who will consume the assigned products for 3 months and be arranged to 3 site visits. All relevant clinical data will be captured and recorded into CTMS (Clinical Trial Management System) for statistical analysis and reporting. Researchers will compare the three study groups to conclude how Amway uric acid lowering product will improve hyperuricemia.

Conditions

• Hyperuricemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Study Product A (High-dose 2X)	participants in this arm will consume 1 sachet of this product with 200ml water per time, once a day after meal, for 3 months
DIETARY_SUPPLEMENT	Study Product B (Low-dose X)	participants in this arm will consume 1 sachet of this product with 200ml water per time, once a day after meal, for 3 months
DIETARY_SUPPLEMENT	Placebo	participants in this arm will consume 1 sachet of this product with 200ml water per time, once a day after meal, for 3 months

Timeline

• Start date: 2023-10-23
• Primary completion: 2024-02-28
• Completion: 2024-03-15
• First posted: 2023-10-16
• Last updated: 2023-10-16

Locations

1 site across 1 country: China